LON:PRM Proteome Sciences Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Proteome Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 3.60 0.00 (0.00%) (As of 07/4/2022 12:00 AM ET) Add Compare Share Today's Range 3.44▼ 3.6050-Day Range 3.41▼ 4.4552-Week Range 3.20▼ 7.50VolumeN/AAverage Volume290,825 shsMarket Capitalization£10.63 millionP/E Ratio41.00Dividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsInsider TradesHeadlines Proteome Sciences MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.69 out of 5 stars 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Proteome Sciences. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for PRM. Previous Next 0.0 Dividend Strength Dividend YieldProteome Sciences does not currently pay a dividend.Dividend GrowthProteome Sciences does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRM. Previous Next 2.2 News and Social Media Coverage News SentimentProteome Sciences has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.Search Interest4 people have searched for PRM on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Proteome Sciences to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Proteome Sciences insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Proteome Sciences is 41.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 74.87.Price to Earnings Ratio vs. SectorThe P/E ratio of Proteome Sciences is 41.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.11. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive PRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address About Proteome Sciences (LON:PRM) StockProteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.Read More PRM Stock News HeadlinesMay 17, 2022 | lse.co.ukProteome Sciences maintains strong order bookDecember 7, 2021 | finance.yahoo.comHere's Why I Think Proteome Sciences (LON:PRM) Might Deserve Your Attention TodayNovember 15, 2021 | finance.yahoo.comThermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument SolutionsSeptember 6, 2021 | finance.yahoo.comA Look At The Fair Value Of Proteome Sciences plc (LON:PRM)June 8, 2021 | finance.yahoo.comI Ran A Stock Scan For Earnings Growth And Proteome Sciences (LON:PRM) Passed With EaseMay 13, 2021 | markets.businessinsider.comProteome Sciences : Price Monitoring ExtensionMay 11, 2021 | markets.businessinsider.comProteome Sciences : AGM StatementMay 11, 2021 | markets.businessinsider.comProteome Sciences : Result of AGMApril 5, 2021 | finance.yahoo.comProteome Sciences plc's (LON:PRM) Price Is Out Of Tune With EarningsMarch 28, 2021 | lse.co.ukProteome profit to be higher than expected thanks to royalties boostMarch 25, 2021 | barrons.comProteome Sciences PLCFebruary 12, 2021 | marketwatch.comBiomarker Research Services Market will Likely see Expanding of Marketable Business Segment | Noble Life Sciences Inc, ReproCELL USA IncJanuary 3, 2021 | markets.businessinsider.comProteome Sciences PLCShs Stock , PMSNFDecember 23, 2020 | benzinga.comGlobal Pancreatic Cancer Diagnostic Tests Devices Pipeline Assessment Report 2020October 10, 2020 | au.finance.yahoo.comPROTEOME SCIENCES PLC Registere (PI2.SG)July 2, 2020 | www.lse.co.ukDIRECTOR DEALINGS: Proteome Sciences Non-Executive Ups InterestJune 26, 2020 | www.lse.co.ukProteome Sciences Outlook Positive; Sales Remain Stable In Five MonthsMarch 4, 2020 | finance.yahoo.comInvestors Who Bought Proteome Sciences (LON:PRM) Shares Five Years Ago Are Now Down 85%January 21, 2020 | www.lse.co.ukProteome Sciences Expects Narrowed Annual Loss On Revenue GrowthDecember 5, 2019 | finance.yahoo.comWhat Did Proteome Sciences plc's (LON:PRM) CEO Take Home Last Year?December 5, 2019 | finance.yahoo.comWhat Did Proteome Sciences plc's (LON:PRM) CEO Take Home Last Year?September 16, 2019 | markets.businessinsider.comBruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF™ Pro Platform at HUPO 2019August 21, 2019 | finance.yahoo.comDid Changing Sentiment Drive Proteome Sciences's (LON:PRM) Share Price Down A Painful 91%?July 1, 2019 | www.morningstar.co.ukProteome Sciences Upgrades Core Products With New ReagentsApril 30, 2019 | www.morningstar.co.ukProteome Sciences Upbeat On Future After "Good" First QuarterSee More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Medical Laboratories & Research Sub-IndustryN/A SectorMedical Current SymbolLON:PRM CUSIPN/A CIKN/A Webwww.proteomics.com Phone+44-20-70432116FaxN/AEmployees24Year FoundedN/ACompany Calendar Last Earnings8/10/2020Today7/04/2022Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio41.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.39 Quick Ratio0.29 Sales & Book Value Annual Sales£5.13 million Price / Sales2.07 Cash FlowGBX 0.80 per share Price / Cash Flow4.50 Book ValueGBX (0.90) per share Price / Book-4.00Miscellaneous Outstanding Shares295,182,000Free FloatN/AMarket Cap£10.63 million OptionableNot Optionable BetaN/A Proteome Sciences Frequently Asked Questions How has Proteome Sciences' stock performed in 2022? Proteome Sciences' stock was trading at GBX 5.13 at the beginning of the year. Since then, PRM shares have decreased by 29.8% and is now trading at GBX 3.60. View the best growth stocks for 2022 here. How were Proteome Sciences' earnings last quarter? Proteome Sciences plc (LON:PRM) posted its earnings results on Monday, August, 10th. The company reported ($0.17) earnings per share for the quarter. View Proteome Sciences' earnings history. Who are Proteome Sciences' key executives? Proteome Sciences' management team includes the following people: Dr. Mariola Sohngen, CEO & Exec. Director (Age 61, Pay $258k)Dr. Ian H. Pike, Chief Scientific Officer & Exec. DirectorMr. Richard Paul Dennis, Chief Commercial Officer & Exec. Director (Age 63, Pay $225k)Mr. Stefan Fuhrmann, Fin. DirectorMr. Glenn Barney, VP of Sales & MarketingVictoria Birse, Company Sec. Who are some of Proteome Sciences' key competitors? Some companies that are related to Proteome Sciences include MDxHealth (MXDHF), Neoleukin Therapeutics (NLTX), Moleculin Biotech (MBRX), Venture Life Group (VLG), Xtant Medical (XTNT), IN8bio (INAB), Ainos (AIMD), Rafael (RFL), Gain Therapeutics (GANX), Isoray (ISR), Isoray (ISR), Immunome (IMNM), Pluristem Therapeutics (PSTI), VentriPoint Diagnostics (VPT) and TSO3 (TOS). View all of PRM's competitors. What other stocks do shareholders of Proteome Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Proteome Sciences investors own include ValiRx (VAL), boohoo group (BOO), Mondi (MNDI), Petrofac (PFC), Lloyds Banking Group (LLOY), Falanx Group (FLX), Quanterix (QTRX), Centrica (CNA), CyanConnode (CYAN) and Eckoh (ECK). What is Proteome Sciences' stock symbol? Proteome Sciences trades on the London Stock Exchange (LON) under the ticker symbol "PRM." How do I buy shares of Proteome Sciences? Shares of PRM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Proteome Sciences' stock price today? One share of PRM stock can currently be purchased for approximately GBX 3.60. How much money does Proteome Sciences make? Proteome Sciences (LON:PRM) has a market capitalization of £10.63 million and generates £5.13 million in revenue each year. How many employees does Proteome Sciences have? Proteome Sciences employs 24 workers across the globe. How can I contact Proteome Sciences? Proteome Sciences' mailing address is Hamilton House, Mabledon Place, LONDON, WC1H 9BB, United Kingdom. The official website for Proteome Sciences is www.proteomics.com. The company can be reached via phone at +44-20-70432116. This page (LON:PRM) was last updated on 7/4/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here